Lv1
42 积分 2021-02-18 加入
Fragment-based approaches to discover ligands for tumor-specific E3 ligases
2个月前
已完结
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
5个月前
已完结
Nanobodies targeting ion channels: advancing therapeutics through precision and structural insights
6个月前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
11个月前
已完结
皖公网安备34019202002308
